US FDA approves Gilead cell therapy for earlier lymphoma
The one-time treatment was initially approved in 2017 for patients with large B-cell lymphoma who did not respond to at least two…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Yescarta
Kite gets US FDA nod for Yescarta to treat relapsed or refractory follicular lymphoma
Yescarta is the first CAR T-Cell therapy approved for indolent follicular lymphoma